bf/NASDAQ:RVLP_icon.jpeg

COM:RVLPHARMA

RVL Pharmaceuticals

  • Stock

Last Close

0.04

20/10 20:00

Market Cap

3.14M

Beta: -

Volume Today

63.96M

Avg: -

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride opht...Show More

peer of

competitor of